| PRIME Research Preceptors | Research Focus | Research Type |
| Benjamin Alman, MD | New drug therapies for musculoskeletal tumors | Translational |
| Andrew Armstrong, MD | Novel therapies and drug development for prostate, renal, bladder, and testicular cancer | Clinical |
| Gerard Blobe, MD, PhD | Role of TGF-ß superfamily signal transduction pathways in cancer biology | Basic |
| Michael Boyce, PhD | Protein glycosylation in mammalian health and disease | Basic |
| Jen-Tsan Ashley Chi, MD, PhD | Nutrient signaling and stress adaptations of cancer cells | Basic |
| Christopher Counter, PhD | Molecular mechanisms underlying the development of cancer | Basic |
| Anna Mae Diehl, MD | Liver injury and repair, including regulated cell death and regeneration | Basic |
| Donald Fox, PhD | Extreme genome variation in organ development and repair | Basic |
| Jennifer Freedman, PhD | Cancer disparities | Translational |
| Katherine Garman, MD | Cancer development in the gastrointestinal tract | Translational |
| Sarah Goetz, PhD | Molecular pathways and roles of cilia in cancer | Basic |
| Zachary Hartman, PhD | Immunity and inflammation in the context of cancer | Basic/ Translational |
| Jiaoti Huang, MD, PhD | Carcinogenesis, biomarkers, diagnosis, and novel therapeutic strategies of prostate cancer | Translational |
| Chuan-Yuan Li, DSc | Mechanisms of skin cancer carcinogenesis; melanoma and squamous cell carcinoma response to therapy; stem cell and regenerative therapy | Basic/ Translational |
| Corinne Linardic, MD | Signaling pathways in rhabdomyosarcoma | Basic |
| Micah Luftig, PhD | Pathogenesis of viruses that cause cancer | Basic |
| Donald McDonnell, PhD | Identification of novel therapeutics for hormonally responsive cancers | Basic/ Translational/ Clinical |
| Steven Patierno, PhD | Molecular biology of cancer disparities; targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness | Translational |
| Ann Marie Pendergast, PhD | Tyrosine kinase-regulated transcription networks in tumor progression to metastasis | Basic |
| Nirmala Ramanujam, PhD | Technology innovations for cancer surveillance | Translational |
| Stefanie Sarantopoulos, MD, PhD | Immunotherapies for leukemia and lymphoma; stem cell therapy | Translational |
| David Sherwood, PhD | Cell invasion, stem cell regulation, and cell-matrix interactions in cancer | Basic |
| Dorothy Sipkins, MD, PhD | Blocking breast cancer relapse | Translational/ Clinical |
| Joshua Snyder, PhD | Cancer cell adaptation and growth before diagnosis | Basic/ Translational |
| Jason Somarelli, PhD | Evolution of cancer drug resistance and metastasis | Translational |
| Beth Sullivan, PhD | Chromosome abnormalities associated with cancer | Basic |
| Kyle Walsh, PhD | Telomere maintenance in pre-malignant cells and development of glioblastoma | Basic |
| Xiao Fan Wang, PhD | Tumor microenvironment changes that impact progression and metastasis | Basic |
| Kris Wood, PhD | Principles underlying the design of new, durable anticancer therapeutic strategies | Translational |
| Jennifer Zhang, PhD | Gene regulation of epithelial cell proliferation; keratinocytes as instigators of inflammatory responses; ubiquitination enzymes in melanoma | Basic |
